Credo Life Science
Posted on 27th January 2022

Posted on 27th January 2022

Tamsulosin is widely prescribed to relieve urinary symptoms caused by benign prostatic hyperplasia (BPH). The standard dosage form is a modified-release capsule containing pellets, and it is a good example of how multiparticulate technology solves real formulation challenges. For pharmaceutical companies looking for a tamsulosin pellets manufacturer, understanding the design and quality attributes of these pellets helps in choosing the right partner.
Tamsulosin hydrochloride is an alpha-1 adrenergic receptor blocker with selectivity for receptors in the prostate and bladder neck. It relaxes smooth muscle in these areas, improving urine flow in men with BPH. It is available as a low-dose product, usually 0.4 mg once daily, and is often combined with other agents such as 5-alpha reductase inhibitors.
Combination Products With Tamsulosin: Tamsulosin is often formulated together with other medicines for BPH in a single capsule. In such products, tamsulosin pellets may be filled alongside other dosage units, which makes pellet size, flow and compatibility particularly important.
Tamsulosin is formulated for gradual release so that blood levels rise gently and stay within an intended range. This helps limit side effects related to peak concentrations, such as dizziness from blood pressure changes.
Low Dose and Content Uniformity: With a dose of less than a milligram, ensuring each capsule contains exactly the right amount of drug is a technical challenge. Drug layering onto inert cores allows precise, uniform distribution of such a small quantity, supporting reliable content uniformity.
Multiple-Unit Advantages: Pellets disperse over a wide area of the gastrointestinal tract, reducing the risk of dose dumping because the failure of a few pellets does not compromise the whole dose.
Four-stage manufacturing process for tamsulosin pellets:
Critical quality attributes that must be verified:
Maintaining uniform drug layering for very small doses, preventing static and loss of drug on equipment surfaces, controlling coating levels to match target release, ensuring scale-up reproducibility, and maintaining stability in warm and humid conditions.
Relevant Technical Experience: Experience with low-dose drug layering and controlled-release coating is a strong indicator of capability.
Analytical Strength & Regulatory Support: Reliable methods for assay, dissolution and impurity profiling are essential, alongside good manufacturing practice, batch documentation, stability data and scale-up capacity.
Packaging and Storage: Tamsulosin pellets are typically packed in sealed containers with protective liners and stored in a cool, dry place away from light and moisture.
Credo Life Sciences focuses on pharmaceutical pellets and granules for formulation companies that need consistent quality, dependable supply and clear technical communication. We understand that a multiparticulate ingredient is only as good as its reproducibility from batch to batch, so our approach centres on controlled processes, thorough documentation and responsive support for your development and commercial needs. We work as a long-term partner to our customers, not just a vendor.
Tamsulosin pellets illustrate how careful design and manufacturing can deliver precise, reliable modified release. For formulators, the choice of pellets manufacturer affects product quality, regulatory success and market reliability. If you are looking for a tamsulosin pellets manufacturer, talk to us about your specification and requirements.
Partner with Credo Life Sciences for your pellet and granule requirements. Contact our team to discuss specifications and quotations.
The modified-release design depends on intact pellets and coating. Breaking them can release the dose too quickly.
Yes. It requires accurate layering and sensitive testing to ensure uniformity.